lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

A Systematic Review of Prediction Models for Tuberculosis Treatment Outcomes

45 Pages Posted: 8 Oct 2020

See all articles by Lauren Saag Peetluk

Lauren Saag Peetluk

Vanderbilt University - Division of Epidemiology

Felipe M. Ridolfi

Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI)

Peter F. Rebeiro

Vanderbilt University - Division of Infectious Diseases

Dandan Liu

Vanderbilt University - Department of Biostatistics

Valeria C. Rolla

Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI)

Timothy R. Sterling

Vanderbilt University - Division of Infectious Diseases

More...

Abstract

Background: Tuberculosis (TB) outcome prediction models are important for informing clinical practice and TB management policies, but existing models have not been systematically reviewed.

Design/Methods: PubMed, Embase, Web of Science, and Google Scholar were searched for studies published January 1, 1995 - January 9, 2020. Studies that developed a model to predict pulmonary TB treatment outcomes were included. Study screening, data extraction, and quality assessment were conducted independently by two reviewers. Study quality was evaluated using the Prediction model Risk Of Bias Assessment Tool (PROBAST). The study was pre-registered on OSF (https://osf.io/rz3wp).

Findings: 14,739 articles were identified, 536 underwent full-text review, and 33 studies presenting 37 prediction models were included. Model outcomes included death (n=16, 43%), treatment failure (n=6, 16%), default (n=6, 16%) or a composite outcome (n=9, 25%). Most models (n=29, 78%) measured discrimination (median c-statistic=0.75; IQR: 0.68-0.84), and 17 (46%) reported calibration, often the Hosmer-Lemeshow test (n=13). Nineteen (51%) models were internally validated, and six (16%) were externally validated. Eighteen studies (54%) mentioned missing data, and of those half (n=9) used complete case analysis. The most common predictors included age, sex, extrapulmonary TB, body mass index (BMI), chest x-ray results, previous TB, and HIV. Risk of bias varied across studies, but all studies had high risk of bias in their analysis.

Interpretation: TB outcome prediction models are heterogeneous with disparate outcome definitions, predictors, and methodology. We do not recommend applying any in clinical settings without external validation, and encourage future researchers adhere to guidelines for developing and reporting of prediction models.

Funding Statement: This work was supported by the National Center for Advancing Translational Sciences [CTSA Award No. TL1TR000447 to L.S.P.].

Declaration of Interests: None declared.

Keywords: Systematic review, Tuberculosis, treatment outcomes, prediction models

Suggested Citation

Peetluk, Lauren Saag and Ridolfi, Felipe M. and Rebeiro, Peter F. and Liu, Dandan and Rolla, Valeria C. and Sterling, Timothy R., A Systematic Review of Prediction Models for Tuberculosis Treatment Outcomes. Available at SSRN: https://ssrn.com/abstract=3675461 or http://dx.doi.org/10.2139/ssrn.3675461

Lauren Saag Peetluk (Contact Author)

Vanderbilt University - Division of Epidemiology ( email )

Nashville, TN
United States

Felipe M. Ridolfi

Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI) ( email )

Av. Brasil 4365
Rio de Janeiro, 21040-360
Brazil

Peter F. Rebeiro

Vanderbilt University - Division of Infectious Diseases ( email )

United States

Dandan Liu

Vanderbilt University - Department of Biostatistics

2301 Vanderbilt Place
Nashville, TN 37240
United States

Valeria C. Rolla

Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI) ( email )

Av. Brasil 4365
Rio de Janeiro, 21040-360
Brazil

Timothy R. Sterling

Vanderbilt University - Division of Infectious Diseases ( email )

United States